The European Medicines Agency’s Committee for Medicinal Products for Human Use recommended the approval of Vyjuvek for the ...
A false claim is circulating online that the European Medicines Agency (EMA) has acknowledged that mRNA vaccines have not ...
The European Medicines Agency’s (EMA) human medicines committee (CHMP) recommended three novel medicines for approval at its ...
FYB202/Otulfi ® (ustekinumab-aauz), a biosimilar to Stelara®, launched in the United States and the European Union FYB202/Otulfi ® is now commercially available in both subcutaneous and intravenous ...
Gilead (GILD) announced that the European Medicines Agency has validated for parallel accelerated review the company’s marketing authorization ...
A false claim is circulating online that the European Medicines Agency (EMA) has acknowledged that mRNA vaccines have not been formally approved and that millions have therefore been vaccinated ...
Medicines account for more than 13 per cent – about €3.3 billion – of a health budget that is permanently under strain. That ...
Neurotech International has received positive feedback from the European Medicines Agency (EMA) on the company’s Orphan ...
Patients should have faster access to newly developed drugs and medicines and the Government is prepared to adopt new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results